$331.40
4.391.34%
At close: -
$331.20
-0.20-0.06%
After Hours: Dec 20, 4:08 PM EDT
Comments
Loading...
West Pharmaceutical Servs (NYSE:WST) Stock, Earnings Estimates, EPS, And Revenue
West Pharmaceutical Servs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 13
EPS Estimate
$1.840
Quarterly Revenue Estimate
$764.9M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.9B
Analyze the earnings history of West Pharmaceutical Servs using advanced sorting and filters.
Data brought to you by Benzinga APIs
West Pharmaceutical Servs (WST) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-24 | $1.85 | $1.50 | 23.3 % |
| Jun 2024 | 2024-07-25 | $1.52 | $1.74 | -12.6 % |
| Mar 2024 | 2024-04-25 | $1.56 | $1.26 | 23.8 % |
| Dec 2023 | 2024-02-15 | $1.83 | $1.78 | 2.81 % |
West Pharmaceutical Servs (WST) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-10-24 | $746.90M | $709.62M | 5.25 % |
| Jun 2024 | 2024-07-25 | $702.10M | $729.35M | -3.74 % |
| Mar 2024 | 2024-04-25 | $695.40M | $670.30M | 3.74 % |
| Dec 2023 | 2024-02-15 | $732.00M | $739.47M | -1.01 % |
FAQ
When is West Pharmaceutical Servs (NYSE:WST) reporting earnings?
West Pharmaceutical Servs (WST) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 24, 2024 for Q3.
What were the latest earnings per share (EPS) for West Pharmaceutical Servs (NYSE:WST)?
The Actual EPS was $1.85, which beat the estimate of $1.50.
What were West Pharmaceutical Servs’s (NYSE:WST) revenues?
The Actual Revenue was $746.9M, which beat the estimate of $709.6M.
Browse earnings estimates, EPS, and revenue on all stocks.